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Summary
The abundance of the human intestinal symbiont
Akkermansia muciniphila has found to be inversely
correlated with several diseases, including metabolic
syndrome and obesity. A. muciniphila is known to
use mucin as sole carbon and nitrogen source. To
study the physiology and the potential for therapeu-
tic applications of this bacterium, we designed a
defined minimal medium. The composition of the
medium was based on the genome-scale metabolic
model of A. muciniphila and the composition of
mucin. Our results indicate that A. muciniphila does
not code for GlmS, the enzyme that mediates the
conversion of fructose-6-phosphate (Fru6P) to glu-
cosamine-6-phosphate (GlcN6P), which is essential
in peptidoglycan formation. The only annotated
enzyme that could mediate this conversion is Amuc-
NagB on locus Amuc_1822. We found that Amuc-
NagB was unable to form GlcN6P from Fru6P at
physiological conditions, while it efficiently catalyzed
the reverse reaction. To overcome this inability, N-
acetylglucosamine needs to be present in the
medium for A. muciniphila growth. With these find-
ings, the genome-scale metabolic model was
updated and used to accurately predict growth of
A. muciniphila on synthetic media. The finding that
A. muciniphila has a necessity for GlcNAc, which is
present in mucin further prompts the adaptation to
its mucosal niche.
Introduction
Akkermansia muciniphila is a mucin-degrading bacterium
that is present in the intestinal tract of a majority of people
(Derrien et al., 2008). Akkermansia muciniphila was first
isolated using purified hog gastric mucus as sole carbon
and nitrogen source (Derrien et al., 2004). In addition to
the degradation of intestinal mucins, A. muciniphila was
shown to be closely associated to colonic epithelial cells
producing these mucins (Derrien et al., 2011). The adap-
tation to this niche is exemplified by the capabilities of
A. muciniphila to utilize low concentrations of oxygen pre-
sent in the mucus layer (Ouwerkerk et al., 2016), even
though it was previously characterized as a strictly anaer-
obic bacterium (Derrien et al., 2004 (Derrien et al., 2004).
The efficient use of mucin by A. muciniphila was shown in
an in vitro intestinal model and upon addition of mucus,
A. muciniphila abundance showed over 10 000-fold
increase, the highest ever observed in this model (Van
Herreweghen et al., 2017).
The mucin in the mucus layer lining the intestinal track
is composed of a peptide backbone abundantly deco-
rated with O-linked glycans (Johansson et al., 2011;
Thomsson et al., 2012). The peptide backbone is rich in
threonine, serine, cysteine and proline, while the glycans
are composed of a plethora of sugar groups that contain
mannose, galactose, fucose and N-acetylhexosamines
such as N-acetylglucosamine (GlcNAc), and N-acetylga-
lactosamine (GalNAc). Akkermansia muciniphila is cap-
able of fermenting some of these sugars including
galactose, fucose, glucose, GlcNAc and GalNAc, which
have been reported to be used for both energy genera-
tion and as carbon source (Desai et al., 2016; Ottman
et al., 2017a). However, the degradation of these sugars
is only possible in the presence of mucin or large
amounts of a tryptic digest of casein (Desai et al., 2016;
Ottman et al., 2017a).
The genome-encoded metabolic potential of
A. muciniphila has been previously exploited to design a
Received 12 July, 2017; revised 8 November, 2017; accepted 10
November, 2017.
*For correspondence. E-mail clara.belzer@wur.nl; Tel. +31 317
483742; Fax +31 317 483829.
Microbial Biotechnology (2018) 0(0), 000–000
doi:10.1111/1751-7915.13033
Funding Information
The work was supported by the Netherlands Organization for
Scientific Research (Spinoza Award and SIAM Gravitation Grant
024.002.002) granted to WMdV. The funding organizations had no
role in design of the study and collection, analysis and interpretation
of data and in writing the manuscript.
ª 2018 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and
reproduction in any medium, provided the original work is properly cited.
bs_bs_banner
genome-scale model of its metabolism (van Passel
et al., 2011; Ottman et al., 2017a). Extensive model
curation and evaluation led to the prediction of an aux-
otrophy for L-threonine as well as predictions regarding
the production of the short-chain fatty acids (SCFA) acet-
ate and propionate, and succinate in the absence of vita-
min B12. The production of these SCFAs was confirmed
by growth experiments, however, in deviating ratios com-
pared with the predictions. The addition of L-threonine to
the growth media did increase growth, but its essentiality
for growth was not confirmed due to the presence of the
partially undefined casein hydrolysate in the medium
(Ottman et al., 2017a).
Inverse correlations have been reported between the
relative abundance of A. muciniphila and diseases and
disorders as reviewed previously (Derrien et al., 2016).
Moreover, in a series of preclinical interventions in mice,
it was shown that A. muciniphila reversed diet-induced
metabolic fat-mass gain and insulin resistance (Everard
et al., 2013; Plovier et al., 2017) possibly due to outer
membrane produced pili (Ottman et al., 2017b; Plovier
et al., 2017). To better understand the physiological
properties, clinical effects and function of A. muciniphila
(Ottman et al., in press), it is essential to have a defined
minimal medium for growth. Such a medium can also be
the basis for the application of A. muciniphila as a thera-
peutic microbe as the medium components should be
defined and preferably of non-animal origin before clini-
cal tests can be conducted. Here, we present a com-
pletely defined and minimal medium that supports
growth of this beneficial microbe. We confirmed that the
amino acid L-threonine is essential for growth and
observed that the addition of either GlcNAc or GalNAc
was essential for the growth of A. muciniphila. Further-
more, we discovered A. muciniphila does not code for a
functional GlmS and hence requires the exogenously
added GlcNAc or GalNAc not only for fermentation, but
also for peptidoglycan formation.
Results and discussion
GlcNAc is essential for A. muciniphila growth
Akkermansia muciniphila was isolated using porcine gas-
tric mucus, and it was shown that this complex substrate
could serve as the sole nitrogen and carbon source
(Derrien et al., 2004). Limited growth was also observed
when large amounts of tryptone, a tryptic digest of
casein, were added as nitrogen source in combination
with monosaccharides (Ottman et al., 2017a). This can
be due to the presence of either amino acids or glycans
in both complex substrates. Hence, the dependency of
A. muciniphila on exogenous nitrogen-containing com-
pounds and sugars was tested in a series of growth
experiments (Fig. 1). The amino sugars tested (GlcNac,
GalNac and GlcN) in these experiments were selected
based on their presence in mucin glycans. We tested
the essentiality of L-threonine by omitting it in the med-
ium in the presence of ammonium and other amino
acids, which resulted in no growth (Fig. S1). This amino
acid was selected based on the A. muciniphila genome-
scale constraint-based model of metabolism, referred to
as ‘the model’ hereafter (Ottman et al., 2017a). The final
composition of the minimal medium is a basal mineral
medium, called CP medium (Derrien et al., 2004;
Plugge, 2005), containing per litre 0.4 g KH2PO4; 0.53 g
Na2HPO4; 0.3 g NaCl; 0.1 g MgCl2 6(H2O); 0.11 g
CaCl2; 1 ml alkaline trace element solution; 1 ml acid
trace element solution; 1 ml vitamin solution; 0.5 mg
resazurin; 4 g NaHCO3; 0.25 g Na 2S.7–9H 2O as
described before, but without ammonium chloride (Der-
rien et al., 2004) and added L-threonine and GlcNAc or
GalNAc. The composition of trace elements and vitamins
was used as described before (Plugge, 2005).
A specific growth rate of 0.056 h1 was observed for
medium containing 25 mM GlcNAc, and a value of
0.084 h1 was found for growth on 25 mM GalNAc
(Table 1), which is no significant difference (P > 0.05).
The specific growth rate was increased from 0.056 h1
to 0.122 h1 when half of the GlcNAc was replaced by
an equimolar amount of glucose, which is a significant
increase (P < 0.05). The final density of the cells is simi-
lar for growth on GlcNAc, GalNAc and GlcNAc/glucose
(Fig. 1). When GlcN was used as substrate, growth was
only observed with the addition of glucose, at a very low
specific growth rate of 0.005 h1.
The consumption and production of metabolites by
A. muciniphila after growth was measured by HPLC and
used to obtain insight into the pathways operating
(Fig. 2), which can be used to study the degradation
Fig. 1. Growth of Akkermansia muciniphila on CP medium supple-
mented with L-threonine and different sugars. All sugars were sup-
plemented to a total of 25 mM. The negative control was
supplemented with GlcNAc/glucose and not inoculated. The data
shown are averages of three biological replicates and two technical
duplicates for each. The experiment was performed twice in dupli-
cate; bars indicate standard deviations.
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pathways of sugars. This analysis showed that the
consumption rates of glucose and GlcNAc were the
same when both were present in the growth medium
(Fig. 2A). The growth differences observed (Fig. 1) could
be influenced by transcriptional adaptations to the pres-
ence of amino sugars. The sugar degradation profiles
(Fig. 2A and D) indicate that glucose is consumed at a
similar rate throughout the analysed time-course, indicat-
ing that no additional adaptations are required for sugar
consumption. In case of GlcNAc and GalNAc degrada-
tion by A. muciniphila, the ratio of acetate and
Table 1. Specific growth rate per hour (l) of Akkermansia mucini-
phila on different sugars, with 6 g/l L-Thr.








Neg. control 0.000 0.000
Fig. 2. SCFA production and degradation of sugars. The degradation of GlcNAc and glucose results in a 1:1 ratio of acetate and propionate
(A). The degradation of GlcNAc and GalNAc results in similar acetate and propionate ratios of 1.5:1 to 2:1 (B, C). The production of acetate
and propionate on glucose and GlcN is in a 1:2 ratio (D). GlcN is still degraded when not supplemented with glucose, but no SCFA production
was observed (E). The experiment was performed twice in duplicate; bars indicate standard deviations.
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propionate production was the same, between 1.5:1 and
2:1 (Fig. 2B and C). Combination of GlcNAc and glu-
cose in the medium leads to a 1:1 ratio (Fig. 2A).
Degradation of glucose in the presence of GlcN pro-
duced acetate and propionate in a 1:2 ratio, GlcN as a
sole carbon source was not able to sustain growth,
nevertheless is degraded albeit in low amounts and did
not contribute to SCFA production (Fig. 2D and E). This
level of SCFA production on glucose was in line with
the predictions by the model (Ottman et al., 2017a), but
not with previous findings in growth experiments where
an acetate to propionate ratio of 1:1 was found (Ottman
et al., 2017a). The accurate determination of SCFA pro-
duction on monosaccharides needed the minimal med-
ium described here as on complex and undefined
media with mucus or casein hydrolysate such measure-
ments were inaccurate.
The production of SCFA after degradation of the
acetylated amino sugars GlcNAc and GalNAc indicated
that these compounds are degraded for the generation
of energy in addition to their possible use for the forma-
tion of peptidoglycan. A ratio of 1.5:1 to 2:1 is in line with
previous findings (Ottman et al., 2017a). The metabolic
model predicts a 5:4 ratio, which slightly lower than the
measured value (Ottman et al., 2017a). The early stag-
nation of growth on GlcN and glucose while there is
some production of SCFA shows that the cells are active
and alive, but limited in growth. This shows again that
either GlcNAc or GalNAc is essential for growth in terms
of biomass formation.
Although it has been suggested that A. muciniphila is
able to degrade GalNAc (Ottman et al., 2017a), the previ-
ous metabolic reconstruction of A. muciniphila contained
no GalNac degradation pathways due to the current lack
of reference degradation pathways in the MetaCyc data-
base (Caspi et al., 2014). The growth of A. muciniphila
on GalNAc could possibly be explained by an isomerizing
step from UDP-GalNAc to UDP-GlcNAc, mediated by the
enzyme UDP-glucose 4-epimerase encoded on locus
Amuc_1125 (AMUC_RS06020) (Thoden et al., 2001;
Bernatchez et al., 2005; van Passel et al., 2011). The
growth of A. muciniphila on GlcN in combination with glu-
cose could be due to acetylation of GlcN6P (Fig. 3). This
acetate group is known to be donated by acetyl-CoA,
which can only be formed if a sugar is degraded first.
Due to this constraint, the growth may be slower because
it requires glucose to form acetyl-CoA. Additionally, from
the metabolic model point of view, growth on GlcN is only
impaired by the lack of a transport mechanism as we
could not identify a gene in the A. muciniphila genome
that would code for a transporter for GlcN. Therefore, it
could be that the transport of GlcN to the cytoplasm is
limited to transportation by other sugars transporters and
thereby very inefficient.
The results indicated that amino sugars (GlcNAc,
GalNAc and limited on GlcN) could support growth of
A. muciniphila, but not glucose or fructose (Table S1).
This suggested that A. muciniphila might lack the ability
to aminate fructose-6-phospgate (Fru6P) to form glu-
cosamine-6-phosphate (GlcN6P), which is an essential
step in peptidoglycan synthesis (Barreteau et al., 2008;
Durand et al., 2008) (Fig. 3). This reaction is catalyzed
by the enzyme GlmS (see below), which mediates the
attachment of an amino group donated by glutamine to
Fru6P to form GlcN6P (Durand et al., 2008). This phos-
phorylated sugar is subsequently converted to N-acetyl-
glucosamine-6-phosphate after the addition of an
acetate group and isomerized to N-acetylglucosamine-1-
phosphate (Barreteau et al., 2008; Fig. 3). The enzyme
GlmS is essential in all peptidoglycan-forming bacteria
(Milewski, 2002), and Escherichia coli glms mutants are
only viable if the growth medium is supplemented with
GlcNAc (Wu and Wu, 1971). This indicates that the
GlcNAc can be phosphorylated and used for peptidogly-
can synthesis directly by A. muciniphila, an Akkermansia
GlcNac shortcut (Fig. 3).
Genomic analysis of A. muciniphila for the identification
of glucosamine-6-phosphate deaminase
We mined the A. muciniphila genome to identify genes
encoding enzymes mediating conversions between
Fru6P and GlcN6P. This lead to the finding that the gen-
ome of A. muciniphila does not code for a gene with
high similarity to a characterized GlmS, see Table S5.
The highest identity to E. coli GlmS was a von Wille-
brand factor type A domain protein (KXT50996.1) with
an identity of 26% and an Expect (E)-value of 0.68, indi-
cating a very low likelihood that this protein is a GlmS
homologue (Table S6) (Altschul et al., 1990, 1994).
There are also no gene homologues to GlmS from Ver-
rucomicrobium spinosum, the type strain for Verrucromi-
crobiae, and thus a relative of A. muciniphila (Table S7).
Therefore, we consider A. muciniphila does not code for
GlmS. The gene that encodes for glucosamine-6-phos-
phate deaminase (CDB55261.1) on locus amuc_1822
(AMUC_RS09725) is the only candidate gene that
expresses an enzyme which could mediate the reaction
between GlcN6P and Fru6P (Table S4). No homologues
were found in the A. muciniphila genome. The analogue
in E. coli is named NagB. The directionality of this
enzyme from different organisms is ambiguous (Vincent
et al., 2005). It has been found to predominantly mediate
the reaction in the deaminating direction, but aminating
activity has been found as well (Tanaka et al., 2005;
Kwiatkowska-Semrau et al., 2015). Hence, we focused
our attention to the kinetic characterization of the
A. muciniphila NagB homologue. It should be noted that
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the recent genome sequencing of 39 A. muciniphila iso-
lates might result in the discovery of genes coding for a
functional NagB homologue, especially because of the
great differences found between strains in the amino
sugar metabolism (Guo et al., 2017).
Enzyme assays confirm the deamination properties of
glucosamine-6-phosphate deaminase
We observed that A. muciniphila was not able to meta-
bolise fructose and does not grow on glucose, while
GlcN supports growth, although very limited (Table 1).
To assess the capabilities of A. muciniphila to convert
fructose-6-phosphate (Fru6P) into glucosamine-6-phos-
phate (GlcN6P) and vice versa, we overproduced the
only possible candidate enzyme, termed Amuc-NagB,
encoded by gene amuc_1822 (AMUC_RS09725) in
E. coli BL21 (DE3) with a C-terminal His-tag and purified
it to apparent homogeneity as a 33-kDa protein
(Fig. S2). The purified Amuc-NagB was assayed for con-
versions in both the aminating and deaminating direction
and with all possible substrates involved (Table S2).
At non-physiological and saturating conditions, we
found that the enzyme Amuc-NagB can mediate the
reaction combining Fru6P and NH4 to produce GlcN6P,
with Km values for Fru6P and NH4 of 5.5  0.9 mM and
41.3  12.8 mM, respectively (Table 2), as calculated
based on triplicate assays. However, the Km of GlcN6P
value for the deaminating direction is much lower at
2.4  0.2 mM (Table 2). The addition of GlcNAc6P as
possible allosteric activator had no significant influence
on the Km values (P > 0.05). On top of this, the activity
Fig. 3. Core biochemical network of Akkermansia muciniphila with the distribution of expected fluxes in the main catabolic pathways under opti-
mal growth conditions described in the article. Arrow width indicates relative changes in the fluxes on different substrates GalNac (red), GlcNac
(blue) and mixture of GlcNac and glucose (yellow). Reactions for which all conditions showed similar fluxes are represented by black arrows.
Model simulations were performed with equimolar total amounts of sugar. Figure has been adapted from (Ottman et al., 2017a).
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of the purified Amuc-NagB on Fru6P with glutamine was
measured to determine the possibility for this enzyme to
mediate the conversion of Fru6P + glutamine 
GlcN6P + glutamate [EC 2.6.1.16]. No activity was found
using these substrates. Additional controls using enzyme
without substrates and substrate without enzyme also
showed no activity (Table S8).
The Km value of 41.3 mM for NH4 is high, but ammo-
nium is not toxic at this concentration (Fig. S3), and
these concentrations are described to be present in the
gut (Macfarlane et al., 1986, 1992). The ammonium pre-
sent in the gut diffuses through the cell to almost equilib-
rium (Muller et al., 2006), so the required ammonium
concentration for the aminating direction could take
place as such in the A. muciniphila cells. However, the
Km value of Fru6P at 5.5 mM is rather high, this com-
pound is described to be toxic in these amounts in many
bacteria (Kadner et al., 1992). Additionally, the Km value
of GlcN6P is lower at 2.4 mM. GlcN6P is the only com-
pound involved in the deaminating direction (Table 2,
Table S8).
The kinetic values found for Amuc-NagB are in line
with previously characterized NagB-like enzymes (Cal-
cagno et al., 1984), except for the absence of the need
for an allosteric activator. In all cases, GlcNAc6P is
described as an allosteric activator (Alvarez-Anorve
et al., 2005, 2016). Our results clearly show that the
overexpressed Amuc-NagB is not allosterically activated
by GlcNAc6P (Table 2).
Considering the kinetic values of Amuc-NagB, it is
unlikely for the aminating reaction to occur at physiologi-
cal conditions, as also postulated before (Calcagno
et al., 1984). We assume an alternative route to
synthesize phosphorylated amino glucoses (GlcN6P,
GlcN1P, GlcNAc6P and GlcNAc1P) is taking place,
which is provided by the addition of non-phosphorylated
GlcNAc or GalNAC to the growth medium. We propose
that GlcNAc can be used by A. muciniphila to form pepti-
doglycan intermediates and ultimately peptidoglycan via
the Akkermansia GlcNac shortcut (Fig. 3).
Optimization of the A. muciniphila genome-scale
constraint-based model of metabolism
The growth on different sugars was compared with pre-
dictions from the A. muciniphila model as presented
before (Ottman et al., 2017a). The initial version of the
model (AkkMuc_588 v1) predicted growth on all sugars
testes, except GlcN, as discussed above. This is in dis-
crepancy with growth in minimal medium and can be
explained by the absence of GlmS that was assumed to
be present in the model due to the use of gap-filling
algorithms (Table 3). Based on these findings, the model
was adjusted by deleting the reaction Fru6P + Glu-
tamine  GlcN6P + Glutamate [EC 2.6.1.16]. This
yielded correct growth predictions for glucose and
GlcNAc. The adjusted model (AkkMuc_588 v2) still did
not predict growth on GalNAc. This was solved by the
additional annotation of UDP-glucose 4-epimerase on
locus Amuc_1125 (AMUC_RS06020) as UDP-GlcNAc 4-
epimerase and which supports the formation of UDP-
GalNAc from GalNAc as discussed above. The epimer-
ase has previously shown to bidirectional mediate the
conversion of UDP-glucose to UDP-galactose and UDP-
GlcNAc to UDP-GalNAc in both bacteria and human
(Thoden et al., 2001; Bernatchez et al., 2005). The
improved version of the model contains 748 reactions
describing conversions among 737 metabolites and can
be found in SBML and table (xls) formats in the Supple-
mentary Information.
Qualitative predictions by the adjusted model (Akk-
Muc_588 v2) showed higher similarity to our laboratory
experiments than the original model (Table 3). The only
small difference between the model and laboratory
experiments is the growth on a medium containing GlcN
and glucose. While the model predicts no growth, a
specific growth rate of 0.005 h1 was observed in the
Table 2. Enzyme kinetics of Akkermansia muciniphila NagB with
and without GlcNAc6P. The addition of 0.25 mM GlcNAc6P as acti-
vator has no influence on the kinetics of the enzyme.
Activator: GlcNAc6P (mM)
Km (mM)
P-value0 (n = 3) 25 (n = 2)
NH4 41.3  12.8 50.6  10.5 0.54
Fru6P 5.5  0.9 8.4  2.7 0.48
GlcN6P 2.4  0.2 2.1  0.8 0.75
Table 3. Growth comparison between in vitro and in silico analyses.
Sugar 1 Sugar 2 AkkMuc_588 v1 (y/n) AkkMuc_588 v2 (y/n) AkkMuc_588 v2 (au) Lab (l) (h1)
Glucose GlcN y n 0 0.005
GlcN n n 0 0
GlcNAc y y 0.09 0.056
GlcNAc Glucose y y 0.13 0.122
GalNAc y y 0.09 0.084
Glucose y n 0 0
ª 2018 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology.
6 K. C. H. van der Ark et al.
laboratory experiment. This could be caused by a limited
uptake of GlcN, even though there is no GlcN trans-
porter annotated. Simulations with an in silico generated
mutant with a hypothetical GlcN transporter show that
the absence of this transporter is the sole reason for the
lack of growth predicted for this sugar. This small uptake
could explain the low growth rate in the presence of both
GlcN and glucose, thereby providing full agreement
between the model qualitative predictions and the exper-
imental results. Nevertheless, the role of glucose
remains unclear, as from the experiments, we see that it
would be essential to enable this possible low uptake
rate.
Concluding, we have shown that GlcNAc or Galnac
with the addition of L-threonine are essential for growth
of A. muciniphila. The dependency on GlcNAc or Gal-
NAc is caused by the absence of a gene coding for
GlmS, which mediates the aminating reaction from
Fru6P to GlcN6P with glutamine as amino donor (Fig. 3),
while Amuc-NagB was shown to be NagB indeed. The
absence of GlmS enzyme and the presence of GlcNAc
in the ecological niche of A. muciniphila resulted in an
alternative pathway for peptidoglycan formation.
This finding supported the development of a growth
medium that allows the use of A. muciniphila in preclini-
cal and phase I clinical trials. Additionally, a minimal
medium can be used for detailed physiological studies,
and manipulation. With this information, we adjusted an
existing genome-scale metabolic model by deleting the
reaction mediated by GlmS. This yielded a more accu-
rate prediction of growth possibilities and growth rate by
the metabolic model compared with the previous version
of the model. The development of the defined minimal
medium for A. muciniphila was based on gathered
knowledge about this species and contributed to a better
understanding of this organism and it evolutionary adap-
tation to mucin components.
Experimental procedures
Culturing A. muciniphila, optical density and HPLC
Akkermansia muciniphila was grown in anoxic bottles
containing 10 ml CP medium as described before with-
out ammonium chloride (Derrien et al., 2004), supple-
mented with 6 g/l of L-threonine. Initial tests were
performed with varying concentrations of GlcNAc (1 mM,
5 mM, and 10 mM) and 50 mM of glucose. Specific
growth rates were seen to increase with increasing
GlcNAc concentration, and 25 mM sugar was selected
for further study, as indicated in Table S1. It should be
noted that we used anoxic bottles to culture the bacteria
and added the sugars with a syringe and filter after auto-
claving. This could yield slightly lower total amounts, but
in all cases, the initial sugar concentrations remained
above 20 mM sugar, except for GluN where a lower
amount of sugar was tested. Inoculum for the determina-
tion of growth speed was grown in basal mineral med-
ium supplemented with 6 g/l L-threonine and 25 mM of
GlcNAc. Inoculum for the determination of sugar essen-
tiality was grown on mucus medium as described before
(Derrien et al., 2004). A volume of 100 ll of cultures in
stationary phase was used as inoculum. Growth was
determined by measuring the optical density at 600 nm.
High-pressure liquid chromatography (HPLC) was used
to determine sugar consumption and SCFA production,
as described before (Derrien et al., 2004; Ouwerkerk
et al., 2016; Ottman et al., 2017a). Glucosamine (GlcN)
concentration was determined by reagent-free ion chro-
matography using a DionexTM ICS-5000 (Thermo Scien-
tific, Sunnyville, CA, USA), with a Dionex CarboPac
PA20 Analytic column and 20 mM NaOH as eluent. Fur-
ther settings were according to manufacturer’s applica-
tion note. Experiments were performed twice in
duplicate; significance of differences was determined by
a paired T-test.
Identification of GlmS and NagB homologues in
A. muciniphila
Escherichia coli K12 NagB (NP_415204.1) and GlmS
(NP_418185.1) amino acid sequences were used to
identify enzymes that can mediate the formation of
GlcN6P from Fru6P in Akkermansia (taxid:239934). This
was performed by selecting best bidirectional blastp (pro-
tein-protein BLAST) hits between both genomes
(Altschul et al., 1990). Analysis was performed on Febru-
ary 10, 2017.
Enzyme expression and purification
The A. muciniphila gene NagB on locus Amuc_1822
(AMUC_RS09725) was amplified using the forward pri-
mer 50-ATAGAGGTACCATGATCGGGGTGGAAAGT-30
and the reverse primer 50- TATGCCCTAGGTTAATGGT
GGTGGTGATGATGAAGGAGGGAAGCAGCCC-30, add-
ing a C-terminal His-tag (bold in primer sequence) and
restriction sites (underlined in primer sequence). Geno-
mic DNA from A. muciniphila ATCC BAA-835 was used
as template. The purified amplicon and vector pCDF-1b
(Novagen, Merck Milipore, Darmstadt, Germany) were
digested using enzymes XmaIJ (Thermo Fisher Scien-
tific) and KpnI HF (New England Biolabs) in Tango buf-
fer (Thermo Fisher Scientific) for 1.5 h at 37°C. The
DNA was purified again and ligated with 3:1 ratio (insert:
vector) using T4 ligase (manufacturers protocol, Thermo
Fisher Scientific). Competent Escherichia coli DH10B
(manufacturers protocol, New England Biolabs) were
transformed with 2 ll ligation mixture and plated on LB
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agar with 50 ug/ml spectinomycin. A selected colony
was grown in 10 ml liquid LB until an OD600 of 1 after
which plasmids were purified. Escherichia coli BL21
(DE3) (manufacturers protocol, New England Biolabs)
was transformed with 1 ll plasmid containing 60 ug/ml
DNA, and 100 ll was plated on LB agar with 50 ug/ml
spectinomycin. The transformed strain was grown in
250 ml liquid LB medium with 50 ug/ml spectinomycin
until an OD600 of 0.5-1 after which is was induced with
1 mM IPTG for 4 h at 37°C. The bacteria were collected
by centrifugation at 5000 g for 10 min and suspended in
lysis buffer (50 mM Tris-HCl pH 7.5, 200 mM NaCl,
1 mM MgCl2, 5 mM DTT, 1 mM PMSF). The cells were
lysed by three passages in a French Press (15 000 psi,
Pressure Cell Homogeniser, Stansted Fluid Power Ltd.,
Essex, UK). The lysate was cleared by centrifugation for
10 min at 16 000 g. The proteins were purified using a
nickel column (manufacturers protocol, Ni-NTA Agarose,
Qiagen GmbH, Hilden, Germany). Purified fractions were
dialyzed against 1 L of buffer A (25 mM KH2PO4/
K2HPO4, pH 7.0, 0.5 mM PMSF, 1 mM DTT, 1 mM
EDTA). Purity of the enzymes was checked using SDS-
PAGE. Enzyme concentration was determined by BCA
protein assay (manufacturers protocol, Thermo Fisher
Scientific).
Enzyme assays
Enzyme assays were performed as described before
(Kwiatkowska-Semrau et al., 2015). Shortly, 1.5 ml tubes
were filled with the buffer and substrates as indicated in
Table S3. The enzymes were added last, after which the
tubes were vortexed shortly and incubated at 37°C for
exactly 3 min. Subsequently, the tubes were placed at
99°C for 1 min and cooled on ice. To acetylate GlcN6P,
100 ll of 10% acetic acid in acetone and 200 ll of a satu-
rated NaHCO3 solution were added, after which the sam-
ples were incubated for 3 min at 20°C and 3 min at 99°C.
The samples were cooled on ice again, after which 200 ll
of a 0.8 M potassium tetraborate hexahydrate solution
was added. The samples were incubated for 3 min at
99°C and cooled on ice. Finally, 800 ll of this solution
was added to 5 ml of reagent A (1 g of 4-dimethylamino-
benzaldehyde in 100 ml of glacial acetic acid to which
1.5 ml 37% HCl is added). The samples were incubated
at 37°C for 30 min, after which the absorbance was mea-
sured at 585 nm (manufacturer). The Km and Vmax val-
ues were determined by plotting the obtained data on a
Lineweaver-Burk plot (Burk et al., 1934).
Genome-scale constraint-based metabolic model
The genome-scale constraint-based model of A. muciniphila
AkkMuc_588 reported previously (Ottman et al., 2017a)
was used to assess growth potential on different media.
The core of the model is S the stoichiometric matrix. S is
an m 9 n matrix, where n is the number of metabolites
and m is the number of reactions in the model, 734 and
745 respectively. Entries of S represent the stoichiomet-
ric coefficients of each metabolite in each reaction. In
addition to reactions describing metabolic interconver-
sions and transport, the model also contain reactions
that describe the media composition and the uptake and
secretion potential of the organism, these are the so-
called exchange reactions. The usual convention (fol-
lowed in the A. muciniphila model) is to represent uptake
and production as negative and positive fluxes through
the exchange reactions respectively. The model was
used to simulate steady state as, in such situation, pro-
duction of intracellular metabolites equals consumption,
and the model was used to identify sets of reactions (or
pathways) that carry flux in such a case. Moreover, flux
balance analysis (FBA) can be used to identify optimal
(maximal or minimal) theoretical values for selected
objectives such as biomass synthesis or metabolite
uptake or production (Orth et al., 2010).
Model simulations were performed by simulating the
experimentally tested media. Unlimited secretion was
allowed for metabolites in the media by setting the upper
bounds of the corresponding exchange reactions to
1000. Abundant metabolites in the media such as water,
P, Mn, Mg, Fe, Cu, Co, Cl, H2O2, sulphate and dimethyl-
benzimidazole, were set to be non-limiting by setting the
lower bounds of the corresponding exchange reactions
to 1000. Simulations involving threonine media supple-
mentation were performed with a limited maximal possi-
ble uptake of 1. For all the tested sugars, a range of
uptake rates between 0 and 10 was tested. Arbitrary
units (a.u.) were used in all simulations. Estimations of
changes in fluxes in different growth conditions were
performed by assessing the variations in the maximum
and minimum flux values through each reaction compati-
ble with maximal growth rate. FBA and model simula-
tions were performed using PYTHON version 2.7.12
(Python, 2017) the COBRAPY LIBRARY (version 0.4.1)
(Ebrahim et al., 2013) and GUROBI SOLVER (Gurobi Opti-
mizer Version 6.5.1 LINUX64) (Gurobi, 2016).
Contributions
All authors read and approved the final manuscript.
Availability of data and materials
The genome-scale metabolic model of Akkermansia
muciniphila AkkMuc_588_v2 is available as supplemen-
tary material together with a list of the changes respect
to the previous version. Supplementary file contains the
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AkkMuc_588_v2 model in SBML level 2 and in table
(xls) format. The file also contains documentation indicat-
ing the changes respect to the previous version. Finally,
to ease model reutilization, we have included a Python
script to perform growth simulations on different media.
The script requires the COBRApy library (and has been
tested with version 0.4.1) (Ebrahim et al., 2013) and an
LP solver such as Gurobi (Gurobi, 2016). This model
was deposited in BioModels (Chelliah et al., 2015) and
assigned the identifier MODEL1710040000.
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Fig. S1. Growth of A. muciniphila on CP medium supple-
mented with 25 mM of each glucose and GlcNAc.
Fig. S2. SDS-PAGE gel of overexpressed protein purifica-
tion using a Ni-column.
Fig. S3. Growth of A. muciniphila on CP medium supple-
mented with 25 mM GlcNAc, 6 g/l Thr and 0 mM or 50 mM
NH4Cl.
Table S1. Composition of tested media.
Table S2. Determination of protein concentrations by BCA
assay used for enzyme assays.
Table S3. Overview of substrates used in enzyme assay.
Table S4. BlastP of Escherichia coli K12 NagB
(NP_415204.1) against Akkermansia (taxid:239934).
Table S5. BlastP of A muciniphila NagB (CDB55261.1)
against all sequence except Akkermansia (taxid:239934).
Table S6. BlastP of Escherichia coli K12 GlmS
(NP_418185.1) against Akkermansia (taxid:239934).
Table S7. BlastP of Verrucromicrobium spinosum GlmS
(WP_009962724.1) against Akkermansia muciniphila.
Table S8. Control reactions for enzyme assay of
A. muciniphila NagB.
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